Ruxolitinib for pediatric patients with treatment-naïve and steroid-refractory acute graft-versus-host disease: the REACH4 studyFranco Locatelli, Cristina Díaz de Heredia, Bénedicte Bruno et al.|Blood|2024Cited by 24